A giant cause has to do with new research underway. The Nationwide Institutes of Well being lately launched large-scale scientific trials to raised perceive, deal with and stop lengthy COVID. One will examine whether or not the COVID-19 therapy Paxlovid can assist to enhance signs of the mysterious situation. One other will research interventions to assist with mind fog, reminiscence loss and different cognitive problems brought on by lengthy COVID. Outcomes from this analysis initiative, which features a few different research, shall be revealed on a rolling foundation.
Over the subsequent yr, Al-Aly is hopeful that we’ll additionally be taught extra about why and the way lengthy COVID happens, or its so-called mechanism. Doing so may lend some perception on the right way to forestall it within the first place, he says. “I do hope 2024 won’t solely additional improve nationwide consciousness of the issue, but in addition our means to deal with it [medically],” he provides.
4. We’ll most likely have new vaccines
Given the altering nature of the virus, it’s doubtless the COVID-19 vaccine shall be up to date subsequent yr to match no matter new variations of the virus are spreading, very like how the flu shot will get up to date yearly, says Rachel Presti, M.D., professor of drugs and medical director of the Infectious Illness Medical Analysis Unit at Washington College College of Medication in St. Louis.
“We’re already seeing [the virus] shift slightly bit away from the vaccine that we’re giving this yr,” despite the fact that this new vaccine, launched in September, is a significantly better match for the present variants than final yr’s vaccine would have been, Presti says.
You may additionally hear extra a couple of mixed flu-COVID vaccine in 2024. That’s as a result of vaccine producers are testing a single shot that helps defend in opposition to each influenza and the coronavirus. Early trial knowledge has produced constructive outcomes, and Part 3 research are within the works.
“I’m actually enthusiastic about them,” Pekosz says. “All the identical causes that you’d get the flu vaccine are the identical causes you’ll get the COVID vaccine, but we’re seeing a very large distinction when it comes to individuals who take the COVID vaccine versus the influenza vaccine.”
In line with knowledge from the Facilities for Illness Management and Prevention (CDC), roughly 42 p.c of adults within the U.S. obtained a flu shot,as of Dec. 14, whereas solely 18 p.c of adults bought the brand new COVID-19 vaccine.
“So I’m hoping {that a} mixture vaccine will actually ship the message to a lot of the inhabitants, notably those that are inclined to extreme COVID or influenza, that, look, right here’s a easy approach so that you can defend your self from each of those very harmful pathogens — one and carried out,” Pekosz says.
Discover more from PressNewsAgency
Subscribe to get the latest posts sent to your email.